Good evening :)
Place Order
Add to Watchlist

Prism Medico and Pharmacy Ltd

PRISMMEDI

Prism Medico and Pharmacy Ltd

PRISMMEDI
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹14 cr, stock is ranked 4,305
High RiskStock is 4.49x as volatile as Nifty
23.765.00% (-1.25)
23.765.00% (-1.25)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹14 cr, stock is ranked 4,305
High RiskStock is 4.49x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Consumer StaplesAgro Products
SmallcapWith a market cap of ₹14 cr, stock is ranked 4,305
High RiskStock is 4.49x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
249.410.99
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.1810.161.47%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Prism Medico and Pharmacy is engaged in wholesale and retail of straw, fodder & other animal/poultry feed technology

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -39.14%, vs industry avg of 5.71%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.18% to 0.01%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue0.150.1620.9636.5326.8916.768.441.273.053.34
Raw Materialssubtract0.080.7920.7335.280.000.000.000.000.003.29
Power & Fuel Costsubtract0.000.000.000.000.000.000.000.000.00
Employee Costsubtract0.000.010.100.250.220.170.190.050.03
Selling & Administrative Expensessubtract0.060.000.130.410.110.090.120.110.41
Operating & Other expensessubtract0.00-0.44-0.090.2626.6116.678.631.212.62
Depreciation/Amortizationsubtract0.010.020.040.030.020.010.010.010.01
Interest & Other Itemssubtract0.000.000.000.000.000.000.000.000.01
Taxes & Other Itemssubtract0.000.000.07-0.07-0.02-0.05-0.13-0.03-0.01-0.01
EPS-0.00-0.55-0.030.61-0.08-0.21-0.63-0.13-0.030.10
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Consumer StaplesAgro Products

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Prism Medico and Pharmacy Ltd-748.230.99
Godrej Agrovet Ltd42.185.191.27%
Gujarat Ambuja Exports Ltd18.302.280.25%
Sanstar Ltd36.359.56

Price Comparison

Compare PRISMMEDI with any stock or ETF
Compare PRISMMEDI with any stock or ETF
PRISMMEDI
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 2.22%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding25.00%0.00%0.00%0.00%75.00%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

PRISMMEDI has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Prism Medico & Pharmacy reports standalone net profit of Rs 0.01 crore in the September 2024 quarter

Net profit of Prism Medico & Pharmacy reported to Rs 0.01 crore in the quarter ended September 2024 as against net loss of Rs 0.05 crore during the previous quarter ended September 2023. Sales rose 866.67% to Rs 0.29 crore in the quarter ended September 2024 as against Rs 0.03 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.290.03 867 OPM %3.45-200.00 - PBDT0.01-0.05 LP PBT0.01-0.05 LP NP0.01-0.05 LP Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to table results

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Prism Medico and Pharmacy AGM scheduled

Prism Medico and Pharmacy announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to conduct board meeting

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 5 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Prism Medico & Pharmacy reports standalone net loss of Rs 0.09 crore in the June 2024 quarter

Net Loss of Prism Medico & Pharmacy reported to Rs 0.09 crore in the quarter ended June 2024 as against net loss of Rs 0.09 crore during the previous quarter ended June 2023. Sales reported to Rs 0.06 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.060 0 OPM %-150.000 - PBDT-0.09-0.09 0 PBT-0.09-0.09 0 NP-0.09-0.09 0 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to hold board meeting

Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Prism Medico & Pharmacy reports standalone net loss of Rs 0.07 crore in the December 2021 quarter

2 years agoBusiness Standard

Prism Medico & Pharmacy reports standalone net loss of Rs 0.05 crore in the June 2021 quarter

3 years agoBusiness Standard

Prism Medico Standalone March 2021 Net Sales At Rs 4.32 Crore, Down 9.57% Y-o-Y

3 years agoMoneycontrol

Prism Medico & Pharmacy reports standalone net profit of Rs 0.26 crore in the December 2020 quarter

3 years agoBusiness Standard